Transmitted drug resistance to Tenofovir/Emtricitabine among persons with newly diagnosed HIV infection in Shenyang city, Northeast China from 2016 to 2018.

Zhen WangBin ZhaoMinghui AnWei SongXue DongXin LiLu WangLin WangWen TianHaibo DingXiaoxu Han

Published in: BMC infectious diseases (2021)

The prevalence of TDR to TDF/FTC is low among newly diagnosed HIV-infected cases in Shenyang, suggesting that TDR may have little impact on the protective effect of the ongoing CROPrEP project in Shenyang city.

Keyphrases

newly diagnosed
antiretroviral therapy
hiv infected
human immunodeficiency virus
risk factors
quality improvement